HHS Creates Biodefense Science Board
HHS has created the National Biodefense Science Board, a 13-member public health advisory panel concerned with chemical, biological, nuclear, and radiological agents. HHS Secretary Mike Leavitt announced it June 19 and said its members -- yet to be chosen by Leavitt -- will give him recommendations for research and development and advice about trends, challenges, and opportunities.
The board was authorized by the Pandemic and All-Hazards Preparedness Act. "This new advisory board will add a wide range of expertise and viewpoints from outside of government to help inform HHS decision-making processes," Leavitt said. Four members will be from the pharmaceutical, biotechnology, and device industries; four from academia; one must be from an organization representing health care consumers; and another must be a practicing health care professional.
To submit a resume or CV for consideration to be a board member, e-mail email@example.com. For further information, contact Dr. Susan Cibulsky at 202-260-7000 or firstname.lastname@example.org. The board's charter and additional information can be found at www.hhs.gov/aspr/omsph/nbsb.